BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30837601)

  • 1. Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [
    Laws MT; Bonomi RE; Kamal S; Gelovani DJ; Llaniguez J; Potukutchi S; Lu X; Mangner T; Gelovani JG
    Sci Rep; 2019 Mar; 9(1):3595. PubMed ID: 30837601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive quantification of SIRT1 expression-activity and pharmacologic inhibition in a rat model of intracerebral glioma using 2-[
    Laws MT; Bonomi RE; Gelovani DJ; Llaniguez J; Lu X; Mangner T; Gelovani JG
    Neurooncol Adv; 2020; 2(1):vdaa006. PubMed ID: 32118205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Histone Deacetylase Class IIa Selective Substrate Radiotracers for PET Imaging of Epigenetic Regulation in the Brain.
    Bonomi R; Mukhopadhyay U; Shavrin A; Yeh HH; Majhi A; Dewage SW; Najjar A; Lu X; Cisneros GA; Tong WP; Alauddin MM; Liu RS; Mangner TJ; Turkman N; Gelovani JG
    PLoS One; 2015; 10(8):e0133512. PubMed ID: 26244761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer's Disease.
    Chen YA; Lu CH; Ke CC; Chiu SJ; Chang CW; Yang BH; Gelovani JG; Liu RS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low- and high-cocaine intake affects the spatial and temporal dynamics of class IIa HDAC expression-activity in the nucleus accumbens and hippocampus of male rats as measured by [18F]TFAHA PET/CT neuroimaging.
    Perrine SA; Alsharif WF; Harutyunyan A; Kamal S; Viola NT; Gelovani JG
    Addict Neurosci; 2022 Dec; 4():. PubMed ID: 36540409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial and temporal dynamics of HDACs class IIa following mild traumatic brain injury in adult rats.
    Kamal SR; Potukutchi S; Gelovani DJ; Bonomi RE; Kallakuri S; Cavanaugh JM; Mangner T; Conti A; Liu RS; Pasqualini R; Arap W; Sidman RL; Perrine SA; Gelovani JG
    Mol Psychiatry; 2022 Mar; 27(3):1683-1693. PubMed ID: 35027678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Contrast PET Imaging with [
    Turkman N; Xu S; Huang CH; Eyermann C; Salino J; Khan P
    J Med Chem; 2023 Apr; 66(8):5611-5621. PubMed ID: 37068265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
    Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Imaging of Sirtuin1 Expression-Activity in Rat Brain Using Positron-Emission Tomography-Magnetic-Resonance Imaging with [
    Bonomi R; Popov V; Laws MT; Gelovani D; Majhi A; Shavrin A; Lu X; Muzik O; Turkman N; Liu R; Mangner T; Gelovani JG
    J Med Chem; 2018 Aug; 61(16):7116-7130. PubMed ID: 30052441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging epigenetic regulation by histone deacetylases in the brain using PET/MRI with ¹⁸F-FAHA.
    Yeh HH; Tian M; Hinz R; Young D; Shavrin A; Mukhapadhyay U; Flores LG; Balatoni J; Soghomonyan S; Jeong HJ; Pal A; Uthamanthil R; Jackson JN; Nishii R; Mizuma H; Onoe H; Kagawa S; Higashi T; Fukumitsu N; Alauddin M; Tong W; Herholz K; Gelovani JG
    Neuroimage; 2013 Jan; 64():630-9. PubMed ID: 22995777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.
    Choi SY; Kee HJ; Jin L; Ryu Y; Sun S; Kim GR; Jeong MH
    Biomed Pharmacother; 2018 May; 101():145-154. PubMed ID: 29482060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting CAIX with [
    Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
    Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, biochemical evaluation, radiolabeling and in vivo imaging with high affinity class-IIa histone deacetylase inhibitor for molecular imaging and targeted therapy.
    Turkman N; Liu D; Pirola I
    Eur J Med Chem; 2022 Jan; 228():114011. PubMed ID: 34875522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class IIa histone deacetylases affect neuronal remodeling and functional outcome after stroke.
    Kassis H; Shehadah A; Li C; Zhang Y; Cui Y; Roberts C; Sadry N; Liu X; Chopp M; Zhang ZG
    Neurochem Int; 2016 Jun; 96():24-31. PubMed ID: 27103167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
    Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
    Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
    Song PJ; Lu QY; Li MY; Li X; Shen F
    J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma.
    Pigeon H; Pérès EA; Truillet C; Jego B; Boumezbeur F; Caillé F; Zinnhardt B; Jacobs AH; Le Bihan D; Winkeler A
    Neuro Oncol; 2019 Jun; 21(6):755-764. PubMed ID: 30721979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach.
    Hsu KC; Liu CY; Lin TE; Hsieh JH; Sung TY; Tseng HJ; Yang JM; Huang WJ
    Sci Rep; 2017 Jun; 7(1):3228. PubMed ID: 28607401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase IIa clinical study of [
    Kondo A; Ishii H; Aoki S; Suzuki M; Nagasawa H; Kubota K; Minamimoto R; Arakawa A; Tominaga M; Arai H
    Ann Nucl Med; 2016 Nov; 30(9):608-618. PubMed ID: 27418267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.